Federal Register / Vol. 74, No. 167 / Monday, August 31, 2009 / Notices 44857 

8989/800–433–3823. (Formerly: Laboratory 

Specialists, Inc.) 

Kroll Laboratory Specialists, Inc., 450 

Southlake Blvd., Richmond, VA 23236. 

804–378–9130. (Formerly: Scientific 

Testing Laboratories, Inc.; Kroll Scientific 

Testing Laboratories, Inc.) 

Laboratory Corporation of America Holdings, 

7207 N. Gessner Road, Houston, TX 77040. 

713–856–8288/800–800–2387. 

Laboratory Corporation of America Holdings, 

69 First Ave., Raritan, NJ 08869. 908–526– 

2400/800–437–4986. (Formerly: Roche 

Biomedical Laboratories, Inc.) 

Laboratory Corporation of America Holdings, 

1904 Alexander Drive, Research Triangle 

Park, NC 27709. 919–572–6900/800–833– 

3984. (Formerly: LabCorp Occupational 

Testing Services, Inc., CompuChem 

Laboratories, Inc.; CompuChem 

Laboratories, Inc., A Subsidiary of Roche 

Biomedical Laboratory; Roche 

CompuChem Laboratories, Inc., A Member 

of the Roche Group.) 

Laboratory Corporation of America Holdings, 

1120 Main Street, Southaven, MS 38671. 

866–827–8042/800–233–6339. (Formerly: 

LabCorp Occupational Testing Services, 

Inc.; MedExpress/National Laboratory 

Center.) 

LabOne, Inc. d/b/a Quest Diagnostics, 10101 

Renner Blvd., Lenexa, KS 66219. 913–888– 

3927/800–873–8845. (Formerly: Quest 

Diagnostics Incorporated; LabOne, Inc.; 

Center for Laboratory Services, a Division 

of LabOne, Inc.) 

Maxxam Analytics,* 6740 Campobello Road, 

Mississauga, ON, Canada L5N 2L8. 905– 

817–5700. (Formerly: Maxxam Analytics 

Inc., NOVAMANN (Ontario), Inc.) 

MedTox Laboratories, Inc., 402 W. County 

Road D, St. Paul, MN 55112. 651–636– 

7466/800–832–3244. 

MetroLab-Legacy Laboratory Services, 1225 

NE 2nd Ave., Portland, OR 97232. 503– 

413–5295/800–950–5295. 

Minneapolis Veterans Affairs Medical Center, 

Forensic Toxicology Laboratory, 1 Veterans 

Drive, Minneapolis, MN 55417. 612–725– 

2088. 

National Toxicology Laboratories, Inc., 1100 

California Ave., Bakersfield, CA 93304. 

661–322–4250/800–350–3515. 

One Source Toxicology Laboratory, Inc., 1213 

Genoa-Red Bluff, Pasadena, TX 77504. 

888–747–3774. (Formerly: University of 

Texas Medical Branch, Clinical Chemistry 

Division; UTMB Pathology-Toxicology 

Laboratory.) 

Pacific Toxicology Laboratories, 9348 DeSoto 

Ave., Chatsworth, CA 91311. 800–328– 

6942. (Formerly: Centinela Hospital 

Airport Toxicology Laboratory.) 

Pathology Associates Medical Laboratories, 

110 West Cliff Dr., Spokane, WA 99204. 

509–755–8991/800–541–7891x7. 

Phamatech, Inc., 10151 Barnes Canyon Road, 

San Diego, CA 92121. 858–643–5555. 

Quest Diagnostics Incorporated, 3175 

Presidential Dr., Atlanta, GA 30340. 770– 

452–1590/800–729–6432. (Formerly: 

SmithKline Beecham Clinical Laboratories; 

SmithKline Bio-Science Laboratories.) 

Quest Diagnostics Incorporated, 400 Egypt 

Road, Norristown, PA 19403. 610–631– 

4600/877–642–2216. (Formerly: 

SmithKline Beecham Clinical Laboratories; 

SmithKline Bio-Science Laboratories.) 

Quest Diagnostics Incorporated, 7600 Tyrone 

Ave., Van Nuys, CA 91405. 866–370–6699/ 

818–989–2521. (Formerly: SmithKline 

Beecham Clinical Laboratories.) 

S.E.D. Medical Laboratories, 5601 Office 

Blvd., Albuquerque, NM 87109. 505–727– 

6300/800–999–5227. 

South Bend Medical Foundation, Inc., 530 N. 

Lafayette Blvd., South Bend, IN 46601. 

574–234–4176 x276. 

Southwest Laboratories, 4625 E. Cotton 

Center Boulevard, Suite 177, Phoenix, AZ 

85040. 602–438–8507/800–279–0027. 

St. Anthony Hospital Toxicology Laboratory, 

1000 N. Lee St., Oklahoma City, OK 73101. 

405–272–7052. 

STERLING Reference Laboratories, 2617 East 

L Street, Tacoma, Washington 98421. 800– 

442–0438. 

Toxicology & Drug Monitoring Laboratory, 

University of Missouri Hospital & Clinics, 

301 Business Loop 70 West, Suite 208, 

Columbia, MO 65203. 573–882–1273. 

Toxicology Testing Service, Inc., 5426 NW. 

79th Ave., Miami, FL 33166. 305–593– 

2260. 

U.S. Army Forensic Toxicology Drug Testing 

Laboratory, 2490 Wilson St., Fort George G. 

Meade, MD 20755–5235. 301–677–7085. 

* The Standards Council of Canada (SCC) 

voted to end its Laboratory Accreditation 

Program for Substance Abuse (LAPSA) 

effective May 12, 1998. Laboratories certified 

through that program were accredited to 

conduct forensic urine drug testing as 

required by U.S. Department of 

Transportation (DOT) regulations. As of that 

date, the certification of those accredited 

Canadian laboratories will continue under 

DOT authority. The responsibility for 

conducting quarterly performance testing 

plus periodic on-site inspections of those 

LAPSA-accredited laboratories was 

transferred to the U.S. HHS, with the HHS’ 

NLCP contractor continuing to have an active 

role in the performance testing and 

laboratory inspection processes. Other 

Canadian laboratories wishing to be 

considered for the NLCP may apply directly 

to the NLCP contractor just as U.S. 

laboratories do. 

Upon finding a Canadian laboratory to be 

qualified, HHS will recommend that DOT 

certify the laboratory (Federal Register, July 

16, 1996) as meeting the minimum standards 

of the Mandatory Guidelines published in the 

Federal Register on April 13, 2004 (69 FR 

19644). After receiving DOT certification, the 

laboratory will be included in the monthly 

list of HHS-certified laboratories and 

participate in the NLCP certification 

maintenance program. 

Elaine Parry, 

Director, Office of Program Services, 

SAMHSA. 

[FR Doc. E9–20932 Filed 8–28–09; 8:45 am] 

BILLING CODE 4162–20–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Board of Scientific Counselors, 

Coordinating Center for Health 

Promotion (BSC, CCHP or the BSC) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the following meeting of the 

aforementioned committee: 

Time and Date: 1 p.m.–5 p.m., September 

15, 2009. 

The call may end before 5 p.m. if business 

is completed. Someone will remain on the 

line until that time to notify callers that the 

call is ended and business complete. 

Place: Teleconference originating from 

CDC, 1825 Century Boulevard, NE., Room 

4066, Atlanta, Georgia 30345. 

Call-in number: (800) 779–9076. 

Participant pass code: 39780. 

If you have a problem in accessing the call, 

call (404) 498–6700. 

Status: This meeting is open to the public 

via the conference line above which will 

accommodate approximately 100 callers. 

Purpose: This BSC is charged with 

providing advice and guidance to the 

Secretary of Health and Human Services, the 

Director of CDC, and the Director of CCHP 

concerning strategies and goals for the 

programs and research within the National 

Center on Birth Defects and Developmental 

Disabilities and the National Center for 

Chronic Disease Prevention and Health 

Promotion. 

Matters To Be Discussed: The agenda will 

include a continuation of the discussion and 

finalization of recommendations to CDC 

leadership as prescribed in the Coordinating 

Center for Health Promotion Charter. Those 

recommendations relate to strategic planning 

for the National Center on Birth Defects and 

Developmental Disabilities as well as the 

results of the BSC’s review of the National 

Center for Chronic Disease Prevention and 

Health Promotion as an organizational unit at 

CDC. 

Providing Oral or Written Comments: It is 

the policy of the BSC, CCHP to provide a 

brief period for oral public comments. In 

general, each individual or group requesting 

to make an oral presentation will be limited 

to a total time of five minutes, if time 

permits. 

Contact Person for Additional Information: 

Karen Steinberg, PhD, Senior Science Officer, 

Coordinating Center for Health Promotion, 

CDC, 4770 Buford Highway, NE., Mailstop E– 

70, Atlanta, Georgia 30341; telephone (404) 

498–6700; fax (404) 498–6880; or via e-mail 

at Karen.Steinberg@cdc.hhs.gov. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register Notices 

pertaining to announcements of meetings and 

other committee management activities, for 

CDC and the Agency for Toxic Substances 

and Disease Registry. 


cprice-sewell on DSK2BSOYB1PROD with NOTICES
44858 Federal Register / Vol. 74, No. 167 / Monday, August 31, 2009 / Notices 

Dated: August 25, 2009. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. E9–20898 Filed 8–28–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Research 

Resources; Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Center for 

Research Resources Special Emphasis Panel; 

ARRA STRB October Meeting 1. 

Date: October 6–9, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, One 

Democracy Plaza, 6701 Democracy 

Boulevard, Bethesda, MD 20892 (Telephone 

Conference Call). 

Contact Person: Mohan Viswanathan, PhD, 

Scientific Review Officer, National Center for 

Research Resources, National Institutes of 

Health, One Democracy Plaza, 6701 

Democracy Blvd., Room 1084, Bethesda, MD 

20892–4874, 301–435–0829, mv10f@nih.gov. 

Name of Committee: National Center for 

Research Resources Special Emphasis Panel; 

ARRA STRB October Meeting 2. 

Date: October 6–9, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, One 

Democracy Plaza, 6701 Democracy 

Boulevard, Bethesda, MD 20892 (Telephone 

Conference Call). 

Contact Person: Mohan Viswanathan, PhD, 

Scientific Review Officer, National Center for 

Research Resources, National Institutes of 

Health, One Democracy Plaza, 6701 

Democracy Blvd., Room 1084, Bethesda, MD 

20892–4874, 301–435–0829, mv10f@nih.gov. 

Name of Committee: National Center for 

Research Resources Special Emphasis Panel; 

ARRA STRB October Meeting 3. 

Date: October 6–9, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, One 

Democracy Plaza, 6701 Democracy 

Boulevard, Bethesda, MD 20892 (Telephone 

Conference Call). 

Contact Person: Carol Lambert, PhD, 

Scientific Review Officer, Office of Review, 

National Institutes of Health, NCRR, 6701 

Democracy Blvd., 1 Democracy Plaza, Room 

1076, MSC 4874, Bethesda, MD 20892 (301)– 

435–0814, lambert@mail.nih.gov. 

Name of Committee: National Center for 

Research Resources Special Emphasis Panel; 

ARRA STRB October Meeting 4. 

Date: October 6–9, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, One 

Democracy Plaza, 6701 Democracy 

Boulevard, Bethesda, MD 20892 (Telephone 

Conference Call). 

Contact Person: Carol Lambert, PhD, 

Scientific Review Officer, Office of Review, 

National Institutes of Health, NCRR, 6701 

Democracy Blvd., 1 Democracy Plaza, Room 

1076, MSC 4874, Bethesda, MD 20892, (301)– 

435–0814, lambert@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research; 93.371, Biomedical 

Technology; 93.389, Research Infrastructure, 

93.306, 93.333; 93.702, ARRA Related 

Construction Awards, National Institutes of 

Health, HHS) 

Dated: August 24, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–20871 Filed 8–28–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Mental Health; 

Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Mental Health Initial Review Group, 

Interventions Committee for Disorders 

Involving Children and Their Families. 

Date: October 5–6, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: St. Gregory Hotel, 2033 M Street, 

NW., Washington, DC 20036. 

Contact Person: David I. Sommers, PhD, 

Scientific Review Officer, Division of 

Extramural Activities, National Institute of 

Mental Health, National Institutes of Health, 

6001 Executive Blvd., Room 6154, MSC 9609, 

Bethesda, MD 20892–9606. 301–443–7861. 

dsommers@mail.nih.gov. 

Name of Committee: National Institute of 

Mental Health Initial Review Group, 

Interventions Committee for Adult Disorders. 

Date: October 13–14, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: St. Gregory Hotel, 2033 M Street, 

NW., Washington, DC 20036. 

Contact Person: David I. Sommers, PhD, 

Scientific Review Officer, Division of 

Extramural Activities, National Institute of 

Mental Health, National Institutes of Health, 

6001 Executive Blvd., Room 6154, MSC 9606, 

Bethesda, MD 20892–9606. 301–443–7861. 

dsommers@mail.nih.gov. 

Name of Committee: National Institute of 

Mental Health Initial Review Group, Mental 

Health Services in Non-Specialty Settings. 

Date: October 13, 2009. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Melrose Hotel, 2430 Pennsylvania 

Ave., NW., Washington, DC 20037. 

Contact Person: Aileen Schulte, PhD, 

Scientific Review Officer, Division of 

Extramural Activities, National Institute of 

Mental Health, NIH, Neuroscience Center, 

6001 Executive Blvd, Room 6140, MSC 9608, 

Bethesda, MD 20892–9608. 301–443–1225. 

aschulte@mail.nih.gov. 

Name of Committee: National Institute of 

Mental Health Initial Review Group, Mental 

Health Services in MH Specialty Settings. 

Date: October 15, 2009. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: St. Gregory Hotel, 2033 M Street, 

NW., Washington, DC 20036. 

Contact Person: Marina Broitman, PhD, 

Scientific Review Administrator, Division of 

Extramural Activities, National Institute of 

Mental Health, NIH, Neuroscience Center, 

6001 Executive Blvd., Room 6153, MSC 9608, 

Bethesda, MD 20892–9608. 301–402–8152. 

mbroitma@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.242, Mental Health Research 

Grants; 93.281, Scientist Development 

Award, Scientist Development Award for 

Clinicians, and Research Scientist Award; 

93.282, Mental Health National Research 

Service Awards for Research Training, 

National Institutes of Health, HHS) 

Dated: August 24, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–20873 Filed 8–28–09; 8:45 am] 

BILLING CODE 4140–01–P 


cprice-sewell on DSK2BSOYB1PROD with NOTICES